ClinicalTrials.gov
public full text
Public Domain
Trial With HuMax-CD4 in Participants With Rheumatoid Arthritis (RA) Failing Treatment With Methotrexate (MTX) and a TNF-alpha Blocker
The purpose of this study is to determine whether HuMax-CD4 is effective in the treatment of active RA in participants who have failed treatment with MTX and at least one TNF-alpha blocking agent.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)#995127
- Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL#1138419
- Comparative, Multicenter Study in Subjects with Rheumatoid Arthritis, ALVOFLEX#865561
- Promoting Engagement in Physical Activity in Early Rheumatoid Arthritis: Proof of Concept Study#871718
- A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis#1153072
Record · ID 833398
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive